285 related articles for article (PubMed ID: 18442364)
1. Transcription analysis in the MeLiM swine model identifies RACK1 as a potential marker of malignancy for human melanocytic proliferation.
Egidy G; Julé S; Bossé P; Bernex F; Geffrotin C; Vincent-Naulleau S; Horak V; Sastre-Garau X; Panthier JJ
Mol Cancer; 2008 Apr; 7():34. PubMed ID: 18442364
[TBL] [Abstract][Full Text] [Related]
2. RACK1, a clue to the diagnosis of cutaneous melanomas in horses.
Campagne C; Julé S; Bernex F; Estrada M; Aubin-Houzelstein G; Panthier JJ; Egidy G
BMC Vet Res; 2012 Jun; 8():95. PubMed ID: 22747534
[TBL] [Abstract][Full Text] [Related]
3. Canine melanoma diagnosis: RACK1 as a potential biological marker.
Campagne C; Julé S; Alleaume C; Bernex F; Ezagal J; Château-Joubert S; Estrada M; Aubin-Houzelstein G; Panthier JJ; Egidy G
Vet Pathol; 2013 Nov; 50(6):1083-90. PubMed ID: 23735618
[TBL] [Abstract][Full Text] [Related]
4. Functional mapping of the promoter region of the GNB2L1 human gene coding for RACK1 scaffold protein.
Del Vecchio I; Zuccotti A; Pisano F; Canneva F; Lenzken SC; Rousset F; Corsini E; Govoni S; Racchi M
Gene; 2009 Feb; 430(1-2):17-29. PubMed ID: 19000751
[TBL] [Abstract][Full Text] [Related]
5. Expression of microtubule-associated protein 2 in benign and malignant melanocytes: implications for differentiation and progression of cutaneous melanoma.
Fang D; Hallman J; Sangha N; Kute TE; Hammarback JA; White WL; Setaluri V
Am J Pathol; 2001 Jun; 158(6):2107-15. PubMed ID: 11395388
[TBL] [Abstract][Full Text] [Related]
6. Opposite regulation of tenascin-C and tenascin-X in MeLiM swine heritable cutaneous malignant melanoma.
Geffrotin C; Horak V; Créchet F; Tricaud Y; Lethias C; Vincent-Naulleau S; Vielh P
Biochim Biophys Acta; 2000 Dec; 1524(2-3):196-202. PubMed ID: 11113568
[TBL] [Abstract][Full Text] [Related]
7. RACK1 suppresses gastric tumorigenesis by stabilizing the β-catenin destruction complex.
Deng YZ; Yao F; Li JJ; Mao ZF; Hu PT; Long LY; Li G; Ji XD; Shi S; Guan DX; Feng YY; Cui L; Li DS; Liu Y; Du X; Guo MZ; Xu LY; Li EM; Wang HY; Xie D
Gastroenterology; 2012 Apr; 142(4):812-823.e15. PubMed ID: 22240482
[TBL] [Abstract][Full Text] [Related]
8. Clinical and histopathological characterization of cutaneous melanomas in the melanoblastoma-bearing Libechov minipig model.
Vincent-Naulleau S; Le Chalony C; Leplat JJ; Bouet S; Bailly C; Spatz A; Vielh P; Avril MF; Tricaud Y; Gruand J; Horak V; Frelat G; Geffrotin C
Pigment Cell Res; 2004 Feb; 17(1):24-35. PubMed ID: 14717842
[TBL] [Abstract][Full Text] [Related]
9. Patterns of melastatin mRNA expression in melanocytic tumors.
Deeds J; Cronin F; Duncan LM
Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
[TBL] [Abstract][Full Text] [Related]
10. Melanoma-Bearing Libechov Minipig (MeLiM): The Unique Swine Model of Hereditary Metastatic Melanoma.
Horak V; Palanova A; Cizkova J; Miltrova V; Vodicka P; Kupcova Skalnikova H
Genes (Basel); 2019 Nov; 10(11):. PubMed ID: 31717496
[TBL] [Abstract][Full Text] [Related]
11. Biochemical characterization of a new melanoma model--the minipig MeLiM strain.
Borovanský J; Horák V; Elleder M; Fortýn K; Smit NP; Kolb AM
Melanoma Res; 2003 Dec; 13(6):543-8. PubMed ID: 14646615
[TBL] [Abstract][Full Text] [Related]
12. Identification of differentially expressed genes in spontaneously regressing melanoma using the MeLiM swine model.
Rambow F; Malek O; Geffrotin C; Leplat JJ; Bouet S; Piton G; Hugot K; Bevilacqua C; Horak V; Vincent-Naulleau S
Pigment Cell Melanoma Res; 2008 Apr; 21(2):147-61. PubMed ID: 18426408
[TBL] [Abstract][Full Text] [Related]
13. Expression of the tumor suppressor gene product p16INK4 in benign and malignant melanocytic lesions.
Keller-Melchior R; Schmidt R; Piepkorn M
J Invest Dermatol; 1998 Jun; 110(6):932-8. PubMed ID: 9620301
[TBL] [Abstract][Full Text] [Related]
14. Intercellular adhesion molecule 1 (ICAM-1) and bcl-2 are differentially expressed in early evolving malignant melanoma.
Collins KA; White WL
Am J Dermatopathol; 1995 Oct; 17(5):429-38. PubMed ID: 8599446
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
[TBL] [Abstract][Full Text] [Related]
16. Tumor progression in the human melanocytic system.
Kath R; Rodeck U; Menssen HD; Mancianti ML; Linnenbach AJ; Elder DE; Herlyn M
Anticancer Res; 1989; 9(4):865-72. PubMed ID: 2554787
[TBL] [Abstract][Full Text] [Related]
17. Gene expression profiles of human melanoma cells with different invasive potential reveal TSPAN8 as a novel mediator of invasion.
Berthier-Vergnes O; El Kharbili M; de la Fouchardière A; Pointecouteau T; Verrando P; Wierinckx A; Lachuer J; Le Naour F; Lamartine J
Br J Cancer; 2011 Jan; 104(1):155-65. PubMed ID: 21081927
[TBL] [Abstract][Full Text] [Related]
18. Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study.
Nazarian RM; Prieto VG; Elder DE; Duncan LM
J Cutan Pathol; 2010 Apr; 37 Suppl 1():41-7. PubMed ID: 20482674
[TBL] [Abstract][Full Text] [Related]
19. Gene expression patterns in melanocytic cells: candidate markers for early stage and malignant transformation.
Meije CB; Hakvoort TB; Swart GW; Westerhof W; Lamers WH; Das PK
J Pathol; 2002 Jan; 196(1):51-8. PubMed ID: 11748642
[TBL] [Abstract][Full Text] [Related]
20. Overexpressions of RACK1 and CD147 associated with poor prognosis in stage T1 pulmonary adenocarcinoma.
Zhong X; Li M; Nie B; Wu F; Zhang L; Wang E; Han Y
Ann Surg Oncol; 2013 Mar; 20(3):1044-52. PubMed ID: 22592183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
